Search research articles
Contact Us
Filters
Showing results (201-210 of 236) with videos related to
Page
of 24
Sort By:
Biorxiv : the Preprint Server for Biology
|
August 30, 2023
Small molecule nitroalkenes inhibit RAD51-mediated homologous recombination and amplify triple-negative breast cancer cell killing by DNA-directed therapies
Lisa Hong, Dennis C Braden, Yaoning Zhao, et al.
Cancer Research
|
October 29, 2021
Transcriptional Reprogramming Differentiates Active from Inactive ESR1 Fusions in Endocrine Therapy-Refractory Metastatic Breast Cancer
Xuxu Gou, Meenakshi Anurag, Jonathan T Lei, et al.
NPJ Breast Cancer
|
July 3, 2019
FGFR4 overexpression and hotspot mutations in metastatic ER+ breast cancer are enriched in the lobular subtype
Kevin M Levine, Nolan Priedigkeit, Ahmed Basudan, et al.
Endocrinology
|
May 8, 2021
A Novel Mouse Model for SNP in Steroid Receptor Co-Activator-1 Reveals Role in Bone Density and Breast Cancer Metastasis
Rebecca J Watters, Kostas Verdelis, Peter C Lucas, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 15, 2017
<i>THADA</i> fusion is a mechanism of IGF2BP3 activation and IGF1R signaling in thyroid cancer
Federica Panebianco, Lindsey M Kelly, Pengyuan Liu, et al.
Biorxiv : the Preprint Server for Biology
|
November 28, 2024
Identification of the MRTFA/SRF pathway as a critical regulator of quiescence in cancer
Santiago Panesso-Gómez, Alexander J Cole, Alyssa Wield, et al.
NPJ Breast Cancer
|
July 20, 2024
International survey on invasive lobular breast cancer identifies priority research questions
Steffi Oesterreich, Leigh Pate, Adrian V Lee, et al.
Cancer Research
|
May 4, 2005
Tumor development by transgenic expression of a constitutively active insulin-like growth factor I receptor
Joan M Carboni, Adrian V Lee, Darryl L Hadsell, et al.
Journal of the National Cancer Institute
|
October 15, 2025
Targeting CDK12 disrupts estrogen-receptor chromatin recruitment and ER-MED1 transcription in advanced ER+ breast cancer
Daniela Ottaviani, Mihaela Ola, Alessandra Allotta, et al.
NPJ Breast Cancer
|
July 13, 2023
Clinicopathologic and genomic features of lobular like invasive mammary carcinoma: is it a distinct entity?
Jing Yu, Edaise M da Silva, Hae-Sun La, et al.
Page
of 24
Search research articles
Search
Showing results (201-210 of 236) with videos related to
Sort By:
Page
of 24
Biorxiv : the Preprint Server for Biology
|
August 30, 2023
Small molecule nitroalkenes inhibit RAD51-mediated homologous recombination and amplify triple-negative breast cancer cell killing by DNA-directed therapies
Lisa Hong, Dennis C Braden, Yaoning Zhao, et al.
Cancer Research
|
October 29, 2021
Transcriptional Reprogramming Differentiates Active from Inactive ESR1 Fusions in Endocrine Therapy-Refractory Metastatic Breast Cancer
Xuxu Gou, Meenakshi Anurag, Jonathan T Lei, et al.
NPJ Breast Cancer
|
July 3, 2019
FGFR4 overexpression and hotspot mutations in metastatic ER+ breast cancer are enriched in the lobular subtype
Kevin M Levine, Nolan Priedigkeit, Ahmed Basudan, et al.
Endocrinology
|
May 8, 2021
A Novel Mouse Model for SNP in Steroid Receptor Co-Activator-1 Reveals Role in Bone Density and Breast Cancer Metastasis
Rebecca J Watters, Kostas Verdelis, Peter C Lucas, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 15, 2017
<i>THADA</i> fusion is a mechanism of IGF2BP3 activation and IGF1R signaling in thyroid cancer
Federica Panebianco, Lindsey M Kelly, Pengyuan Liu, et al.
Biorxiv : the Preprint Server for Biology
|
November 28, 2024
Identification of the MRTFA/SRF pathway as a critical regulator of quiescence in cancer
Santiago Panesso-Gómez, Alexander J Cole, Alyssa Wield, et al.
NPJ Breast Cancer
|
July 20, 2024
International survey on invasive lobular breast cancer identifies priority research questions
Steffi Oesterreich, Leigh Pate, Adrian V Lee, et al.
Cancer Research
|
May 4, 2005
Tumor development by transgenic expression of a constitutively active insulin-like growth factor I receptor
Joan M Carboni, Adrian V Lee, Darryl L Hadsell, et al.
Journal of the National Cancer Institute
|
October 15, 2025
Targeting CDK12 disrupts estrogen-receptor chromatin recruitment and ER-MED1 transcription in advanced ER+ breast cancer
Daniela Ottaviani, Mihaela Ola, Alessandra Allotta, et al.
NPJ Breast Cancer
|
July 13, 2023
Clinicopathologic and genomic features of lobular like invasive mammary carcinoma: is it a distinct entity?
Jing Yu, Edaise M da Silva, Hae-Sun La, et al.
Page
of 24